Clinical Trial Update: A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)

View source ↗

Summary

A completed study assessing how vedolizumab is administered and the outcomes in adults with inflammatory bowel disease (VARIETY-Belgium).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Inflammatory Bowel Diseases, Colitis, Ulcerative | Status: COMPLETED